Join leaders in psychopharmacology, cognitive disorders, and mindfulness for learning and relaxation, offering up to 15 CMEs/CEs at the spectacular Miami Grand Beach Hotel in Miami.
MIAMI, Dec. 16, 2023 /PRNewswire-PRWeb/ -- The University of Miami Leonard M. Miller School of Medicine's Department of Psychiatry and Behavioral Sciences is thrilled to announce registration is now open for their 1st Annual Winter Institutes, taking place at the Miami Grand Beach Hotel in February 2024. This two-week, four-course seminar offers participants the choice of one seminar per week and the opportunity to earn up to 15 CMEs/CEs over the event. During week one (February 19-23, 2024), registrants will be able to choose either Psychopharmacology: A Master Class with Charles B. Nemeroff, M.D., Ph.D., or Mindfulness and Compassion in Clinical Practice: Enhancing Treatment Effectiveness and Personal Wellbeing with Susan Pollak, M.T.S., Ed.D. and Rhoda Moise, Ph.D., CYT. During week two (February 26 – March 1, 2024) of programming, participants will be able to choose either Cognition and the Aging Brain with Elizabeth Crocco, M.D., Rosie Curiel Cid, Psy.D., David Loewenstein, Ph.D., and Phillip Havey, Ph.D. or Essential Psychopharmacology, 2024, Practice and Update with Barbara Coffey, M.D., M.S., Phillip Havey, Ph.D., Luca Pani, M.D., and Dhruti Patel, M.D.
As the first Winter Institutes hosted by the University of Miami Miller School of Medicine's Department of Psychiatry and Behavioral Sciences, Director of Continuing Education Kim Miele has utilized her past 25 years of success in continuing education to elevate Miami's course offerings, "When I was recruited to the University of Miami Miller School of Medicine, Department of Psychiatry and Behavioral Sciences last fall, I knew we had an amazing opportunity to launch a world-class continuing education program in psychiatry. My goal is to connect the brilliant faculty from all over the world I have collaborated with from my time at Beth Israel Deaconess Medical Center and Harvard Medical School with new faculty members from Miami to bring life to the much-needed evidence-based courses we will offer." says Miele. Kim Miele worked under Dr. Lawrence E. Lifson, M.D. at Beth Israel Deaconess Medical Center, a major teaching hospital for Harvard Medical School, for over twenty-five years before joining the University of Miami team. Over that period, Miele administered thousands of hours of programming in psychiatry with the best faculty in the world.
Psychopharmacology: A Master Class (Week 1: February 19-23, 2024)
This seminar offers a holistic perspective on modern neurobiology, encompassing genomics, epigenetics, neurotransmitter systems, and brain circuitry. It underscores the profound impact of early-life trauma on vulnerability to mood and anxiety disorders and explores the pathophysiology of these disorders, with a focus on inflammation and suicide risk. Treatment strategies for depression, anxiety, and women's psychiatric disorders are discussed, emphasizing the use of antipsychotic medications as augmenting agents. Novel approaches like brexanolone and bupropion-dextromethorphan combinations are examined for treatment-resistant depression. The benefits and risks of treatments like ketamine, esketamine, ECT, and TMS are explored.
Additionally, the seminar addresses depression comorbidity with medical illnesses, particularly in cancer and cardiovascular contexts. It delves into the neurobiological mechanisms and treatments for anxiety and anxiety-spectrum disorders, especially post-traumatic stress disorder (PTSD), and highlights advances in personalized and precision medicine, including the controversial use of pharmacogenomic tests. Finally, the growing field of psychedelic medicine in psychiatry is comprehensively reviewed, with a strong emphasis on the importance of the therapeutic alliance when prescribing psychotropic medications.
Mindfulness and Compassion in Clinical Practice: Enhancing Treatment Effectiveness and Personal Wellbeing (Week 1: February 19-23, 2024)
Mindfulness meditation is a widely researched and effective treatment method in mental and behavioral health. It has been shown to manage emotional distress, including anxiety, depression, hypertension, irritable bowel syndrome, chronic pain, and substance abuse, while also improving overall physical and psychological well-being. Research indicates mindfulness meditation can positively affect brain structure and function, reduce stress hormones, and boost the immune system. Over the past two decades, mindfulness has evolved into empirically supported behavior therapy and is at the forefront of mental health treatment. Compassion and, more recently, self-compassion are emerging areas in mindfulness research and training.
While scientific research on meditation dates to the 1970s, the recent surge of mindfulness research has left many healthcare professionals wondering about its precise meaning, how to practice and teach it, and the supporting evidence. This course aims to supply an updated overview of mindfulness in healthcare, including its application to psychotherapy to enhance behavioral treatment, clinician well-being, and positive attitudes in patient care.
Cognition and the Aging Brain (Week 2: February 26-March 1, 2024)
Promoting brain health is crucial for successful aging, enabling individuals to maximize their potential across cognitive, socio-emotional, and behavioral domains. Cognitive disorders, particularly Alzheimer's Disease and Related Dementias (ADRD), are on the rise as people live longer. Preventing these disorders is as vital as reducing conditions like hypertension and diabetes to prevent cardiovascular disease. This course educates healthcare practitioners, equipping them with the knowledge and advanced scientific methods necessary to diagnose ADRD in its earliest stages. It empowers them to differentiate between various cognitive syndromes and understand their underlying causes. Participants will also become familiar with innovative techniques, such as neuropsychological assessments, novel neuroimaging, and plasma-based biomarkers, to detect early signs of Alzheimer's Disease. The presentation covers emerging pharmacological treatments and underscores the significance of cultural diversity and family involvement in managing ADRD.
Essential Psychopharmacology, 2024, Practice and Update (Week 2: February 26-March 1, 2023)
Explore the complex interactions between neurobiology and clinical pharmacology with this comprehensive seminar. Beginning with a fundamental understanding of neurotransmission in the central nervous system, we expand our exploration to encompass the principles that – still today – bridge the art and science of clinical pharmacology. This course illuminates the challenges of bipolar depression, magnifies the enduring efficacy of mood stabilizers such as lithium salts, and delves deep into the complex landscape of schizophrenia, bipolar disorders, and their evolving treatments. We emphasize early intervention and prevention in psychosis, addressing coexisting challenges of substance abuse, and provide a detailed examination of child and adolescent psychopharmacology. By interweaving innovative research with practical clinical insights, this seminar aims to bolster your therapeutic decision-making, optimizing patient outcomes in varied psychiatric disturbances.
This event will occur at the Miami Grand Beach Hotel in Miami from February 19 to March 1, 2024. To reserve a seat at any of these four in-person continuing education seminars and find more information about each course and the course directors, click https://umiami-cme.org/. For more information about the University of Miami Department of Psychiatry and Behavioral Sciences, please visit https://med.miami.edu/departments/psychiatry.
Media Contact
Andrew Nugent, University of Miami Department of Psychiatry and Behavioral Sciences, 1 617-226-1900, [email protected], https://med.miami.edu/departments/psychiatry
SOURCE University of Miami Department of Psychiatry and Behavioral Sciences
Share this article